• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Frenova discloses F1RST Up clinical trial accelerator participants

Frenova discloses F1RST Up clinical trial accelerator participants

June 15, 2016 By Mark Hollmer

Frenova Renal ResearchFour months after it launched a clinical trial accelerator, Fresenius‘s (NYSE:FMS) renal research arm Frenova disclosed the initial participants.

Fourteen research centers around the U.S. will take part in the F1RST Up accelerator (Frenova Rapid Start Up). Frenova general manager said in prepared remarks that the participants include “some of the most productive clinical research sites in the world of renal research.”

The Waltham, Mass.-based accelerator is designed to propel more studies by taking administrative and contracting burdens out of the clinical trial setup process. Frenova launched F1RST Up in February. Frenova itself was relaunched in March 2014, after having been known as the Clinical Studies Group at FMCNA since its 2001 debut.

The 14 participants: Boise Kidney & Hypertension Institute, Meridian, ID; California Institute of Renal Research, San Diego, CAEastern Nephrology Associates, New Bern, NC; Gamma Medical Research, McAllen, TX; Knoxville Kidney Center, Knoxville, TN; Metro Hypertension & Kidney Center, St. Louis, MO; Nephrology & Hypertension Associates, Tupelo, MS; Nephrology Associates, Columbus, MS; Northeast Clinical Research Center, Bethlehem, PA; Paragon Health d/b/a Nephrology Center, Kalamazoo, MI; Renal Medicine Associates, Albuquerque, NM; South Carolina Nephrology and Hypertension Center, Orangeburg, SC; South Florida Research Institute, Lauderdale Lakes, FL; and Southwest Houston Research, Houston, TX.

In February, Frenova launched the renal research accelerator through an alliance of physician investigators in the nephrology research field.

The accelerator aims to boost study startup through the elimination of administrative and contracting burdens that plague clinical trials, and are often responsible for delays, the Waltham, Mass.-based company said.

Filed Under: Business/Financial News, Clinical Trials Tagged With: Frenova Renal Research, Fresenius

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy